bpc-157 fda approved approval status not peptide Repost @peptides with @use.repost ・・・ BREAKING NEWS! Today's FDA advisers back BPC-157 and

Many drugs look promising in cells, mice, or tissue samples but fail in later stages because: The treatment doesnt work well enough in humans It causes side effects at real doses The effect fades over time The human joint environment is much more complex than the lab So while we are hopeful, there is a long road ahead before this approach could become a real treatment

Because BPC-157 has not been extensively studied in humans, no one knows if there is a safe dose, or if there is any way to use this compound safely to treat specific medical conditions

Because every source you find gives different dosing advice

No human trial has confirmed this for retatrutide protocols specifically - the case is mechanistic plus community observation

The key is following a gradual titration schedule that increases every four weeks rather than jumping directly to higher doses

2012;302:L1529